Both in Biotechnology
Liminatus Pharma vs Creative Medical Technology Holdings
Over the past year LIMN returned −95.6% and CELZ returned −77.1%; their daily moves had a correlation of 0.05.
LIMN −95.6% CELZ −77.1%Growth of $1, one year, split-adjusted
| Metric | LIMN | CELZ |
|---|---|---|
| Price | $2.79 | $0.6519 |
| Market cap | $3.8M | $4.9M |
| Today | +0.16% | −3.21% |
| 1 month | −24.5% | −27.6% |
| 6 months | −72.7% | −70.8% |
| Year to date | −90.8% | −66.7% |
| 1 year | −95.8% | −78.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1,649.9× |
| Net cash | — | $8.7M |
| Dividend yield | — | — |
| Volatility (60d) | 1,152.5% | 77.1% |
| Short % of float | 4.6% | 1.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).